Show simple item record

PD-1/PD-L1 mediated T-cell dysfunction in CLL is not absolute and can be at least partially reversed in vivo by the immune-modulatory drug lenalidomide

dc.contributor.authorMcClanahan, Fen_US
dc.contributor.authorRiches, JCen_US
dc.contributor.authorMiller, Sen_US
dc.contributor.authorGhazaly, Een_US
dc.contributor.authorDay, Wen_US
dc.contributor.authorCapasso, Men_US
dc.contributor.authorGribben, Jen_US
dc.date.accessioned2015-02-20T08:47:38Z
dc.date.issued2014-10en_US
dc.identifier.issn2296-5270en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/6568
dc.format.extent236 - 236en_US
dc.relation.ispartofONCOLOGY RESEARCH AND TREATMENTen_US
dc.titlePD-1/PD-L1 mediated T-cell dysfunction in CLL is not absolute and can be at least partially reversed in vivo by the immune-modulatory drug lenalidomideen_US
dc.typeArticle
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343816900576&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume37en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record